Rotavirus Disease in Uzbekistan: Cost-Effectiveness of a New Vaccine

Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.

Author(s): Isakbaeva E, Musabaevc E, Antil L, et al.

Published: 2007

  • Download file (Russian)

    161 KB PDF

  • Visit web page (English)

    (Located at www.sciencedirect.com)

    Citation: Isakbaeva E, Musabaev E, Antil L, et al. Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine. Vaccine. 2007;25(2):373-380.